13F
中

LFVN LIFEVANTAGE CORP

2026Q1 · CUSIP 53222K205 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
102
Δ holders QoQ
-6
Breadth percentile
Top 80%
Whale holders
50
Δ whales
-9
Inst. holding value
$33M
New positions
22
Closed positions
28
Price momentum (1Q)
—
Put / Call
1/1

Breadth history (34 quarters)

2018Q1: Δ+1 · h=46 2018Q2: Δ+1 · h=47 2018Q3: Δ+19 · h=66 2018Q4: Δ+6 · h=72 2019Q1: Δ+4 · h=76 2019Q2: Δ+3 · h=79 2019Q3: Δ+1 · h=80 2019Q4: Δ+6 · h=86 2020Q1: Δ+5 · h=91 2020Q2: Δ-8 · h=83 2020Q3: Δ+5 · h=88 2020Q4: Δ+1 · h=89 2021Q1: Δ-6 · h=83 2021Q2: Δ-6 · h=77 2021Q3: Δ-15 · h=62 2021Q4: Δ-10 · h=52 2022Q1: Δ-4 · h=48 2022Q2: Δ+1 · h=49 2022Q3: Δ-1 · h=48 2022Q4: Δ-4 · h=44 2023Q1: Δ+0 · h=44 2023Q2: Δ+4 · h=48 2023Q3: Δ+5 · h=53 2023Q4: Δ+0 · h=53 2024Q1: Δ-1 · h=52 2024Q2: Δ+4 · h=56 2024Q3: Δ+12 · h=68 2024Q4: Δ+8 · h=76 2025Q1: Δ+27 · h=103 2025Q2: Δ+7 · h=110 2025Q3: Δ-6 · h=104 2025Q4: Δ+4 · h=108 2026Q1: Δ-6 · h=102 2018Q1: holders=46 2018Q2: holders=47 2018Q3: holders=66 2018Q4: holders=72 2019Q1: holders=76 2019Q2: holders=79 2019Q3: holders=80 2019Q4: holders=86 2020Q1: holders=91 2020Q2: holders=83 2020Q3: holders=88 2020Q4: holders=89 2021Q1: holders=83 2021Q2: holders=77 2021Q3: holders=62 2021Q4: holders=52 2022Q1: holders=48 2022Q2: holders=49 2022Q3: holders=48 2022Q4: holders=44 2023Q1: holders=44 2023Q2: holders=48 2023Q3: holders=53 2023Q4: holders=53 2024Q1: holders=52 2024Q2: holders=56 2024Q3: holders=68 2024Q4: holders=76 2025Q1: holders=103 2025Q2: holders=110 2025Q3: holders=104 2025Q4: holders=108 2026Q1: holders=102 -27 -13.5 +0 +13.5 +27 3978116 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 7% — —
2020Q1 Top 15% — —
2018Q3 Top 11% — —

Options Sentiment

Put holders
1
QoQ: 0
Call holders
1
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
13.5
EPS (TTM)
$0.46
EPS YoY
-33.3%
Revenue (TTM)
$0.2B
Revenue YoY
-12.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $51M 2022-09-30: $52M 2022-12-31: $54M 2023-03-31: $54M 2023-06-30: $54M 2023-09-30: $51M 2023-12-31: $52M 2024-03-31: $48M 2024-06-30: $49M 2024-09-30: $47M 2024-12-31: $68M 2025-03-31: $58M 2025-06-30: $55M 2025-09-30: $48M 2025-12-31: $49M 2026-03-31: $44M 2022-06-30: EPS -0.11 2022-09-30: EPS 0.05 2022-12-31: EPS -0.08 2023-03-31: EPS 0.08 2023-06-30: EPS 0.15 2023-09-30: EPS 0.05 2023-12-31: EPS -0.05 2024-03-31: EPS 0.13 2024-06-30: EPS 0.10 2024-09-30: EPS 0.14 2024-12-31: EPS 0.19 2025-03-31: EPS 0.26 2025-06-30: EPS 0.16 2025-09-30: EPS 0.17 2025-12-31: EPS 0.02 2026-03-31: EPS 0.11 0M 34M 68M $M -0.12 0.08 0.29 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 23 2023-06-30: PE 24.32023-09-30: PE 23.12023-12-31: PE 28.32024-03-31: PE 23.22024-06-30: PE 33.62024-09-30: PE 41.72024-12-31: PE 32.12025-03-31: PE 18.82025-06-30: PE 17.52025-09-30: PE 8.32025-12-31: PE 8.12026-03-31: PE 11.2 7 26 44 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)